NasdaqCM - Nasdaq Real Time Price USD
Cidara Therapeutics, Inc. (CDTX)
19.00
-0.36
(-1.89%)
As of 2:50:43 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 472,216 | 3 |
| Sales | 3,437 | 2 |
| Net Shares Purchased (Sold) | 468,779 | 5 |
| Total Insider Shares Held | 166.27k | -- |
| % Net Shares Purchased (Sold) | -155.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DAVARPANAH NICOLE NEGAR Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 1, 2025 |
| WARD SHANE M Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 31, 2025 |
| WARD SHANE M Chief Operating Officer | Sale at price 21.96 per share. | Direct | 36,542 | Mar 11, 2025 |
| TARI LESLIE Officer | Sale at price 21.96 per share. | Direct | 38,940 | Mar 11, 2025 |
| KARBE FRANK L Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2025 |
| RA CAPITAL MANAGEMENT, L.P. Director | Stock Award(Grant) at price 19.59 per share. | Indirect | 7,634,536 | Nov 26, 2024 |
| SANDISON TAYLOR Officer | Sale at price 11.64 per share. | Direct | 10,752 | Sep 11, 2024 |
| TARI LESLIE Officer | Sale at price 11.64 per share. | Direct | 10,580 | Sep 11, 2024 |
| RA CAPITAL MANAGEMENT, L.P. Unknown | -- | Indirect | -- | Jul 19, 2024 |
| STEIN JEFFREY Chief Executive Officer | Purchase at price 13.21 per share. | Indirect | 105,680 | Jun 7, 2024 |
| WARD SHANE M Chief Operating Officer | -- | Direct | -- | Mar 15, 2024 |
| SANDISON TAYLOR Officer | -- | Direct | -- | Mar 15, 2024 |
| SHAH PREETAM Chief Financial Officer | -- | Direct | -- | Mar 15, 2024 |
| TARI LESLIE Officer | -- | Direct | -- | Mar 15, 2024 |
| WARD SHANE M Chief Operating Officer | Sale at price 0.67 per share. | Direct | 13,713 | Mar 11, 2024 |
| SANDISON TAYLOR Officer | Sale at price 0.67 per share. | Direct | 13,839 | Mar 11, 2024 |
| SHAH PREETAM Chief Financial Officer | Sale at price 0.67 per share. | Direct | 12,680 | Mar 11, 2024 |
| TARI LESLIE Officer | Sale at price 0.67 per share. | Direct | 14,085 | Mar 11, 2024 |
| SANDISON TAYLOR Officer | Sale at price 0.95 per share. | Direct | 17,810 | Sep 11, 2023 |
| TARI LESLIE Officer | Sale at price 0.95 per share. | Direct | 17,509 | Sep 11, 2023 |
| TARI LESLIE Officer | Purchase at price 0.97 per share. | Direct | 9,700 | Aug 14, 2023 |
| STEIN JEFFREY Chief Executive Officer | Purchase at price 0.96 per share. | Indirect | 47,885 | Aug 8, 2023 |
Related Tickers
DNTH Dianthus Therapeutics, Inc.
18.68
-0.88%
GLYC GlycoMimetics, Inc.
0.2469
-2.37%
EWTX Edgewise Therapeutics, Inc.
14.11
-5.27%
SYRE Spyre Therapeutics, Inc.
14.54
-1.42%
VRDN Viridian Therapeutics, Inc.
12.09
-5.62%
IDYA IDEAYA Biosciences, Inc.
17.20
-1.43%
KYMR Kymera Therapeutics, Inc.
29.83
-4.21%
SNDX Syndax Pharmaceuticals, Inc.
9.51
-6.72%
JANX Janux Therapeutics, Inc.
22.89
-9.63%
ERAS Erasca, Inc.
1.2550
-5.64%